Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Bilfinger Berger Buys Tebodin - Quick Facts

Bilfinger Berger (BFLBY.PK) said it has acquired Tebodin. The purchase price amounts to 145 million euros. Tebodin, which generates an annual output volume of 225 million euros and has 3,200 employees, is being sold by the Dutch Royal BAM Group.

Tebodin will serve as the basis for the establishment of a new Subgroup at Bilfinger Berger in the area of engineering and technologies. The company will be allocated to the Industrial Services reporting segment.

Bilfinger Berger is also applying its expertise in power plant technology to a joint venture with Tyazhmash, the Russian power plant outfitter. The newly-founded joint venture with power plant outfitter Tyazhmash has set itself the goal of playing a significant role in the required modernization of the Russian power plant network.

Bilfinger Berger holds a 51 percent stake in the new Bilfinger Babcock Tyazhmash.

Click here to receive FREE breaking news email alerts for Bilfinger Berger AG and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Computer and printer maker Hewlett-Packard Co. (HPQ) said Wednesday after the markets closed that its third quarter profit fell 29% from last year, hurt mainly by higher restructuring charges even as revenue grew 1%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue beat analysts' forecast. Stocks fluctuated over the course of the trading day on Wednesday before ending the session mostly higher. The Dow and the S&P 500 both finished the day in positive territory, although the tech-heavy Nasdaq posted a modest loss. President Barack Obama spoke harshly of the terrorist group allegedly responsible for the execution of American freelance journalist James Foley in a statement on Wednesday. Obama described the group known as the Islamic State of Iraq and the Levant, or ISIL, as a cancer that needs to be extracted.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.